Heavy Menstrual Bleeding Clinical Trial
Official title:
Quality of Life Outcomes for Ulipristal Acetate and Tranexamic Acid in the Management of Heavy Menstrual Bleeding: A Pilot Randomized Control Trial
This study compares two treatments for the management of heavy menstrual bleeding, ulipristal acetate (UPA) and tranexamic acid (TEA), on health-related quality of life. Half of the participants will receive UPA and a placebo, and the other half will receive TEA and a placebo.
UPA is approved by Health Canada for the treatment of signs and symptoms of uterine fibroids
in adult women of reproductive age who are eligible for surgery. UPA is considered
investigational for this study, as it has not been approved by Health Canada for the
treatment of heavy menstrual bleeding in women who do not have uterine fibroids.
TEA is approved by Health Canada for prevention or reduction of bleeding in different
conditions, including heavy periods. This treatment is available as part of routine care for
regular heavy menstrual bleeding and is being used as the comparison treatment in this study.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02934789 -
Effectiveness of Truclear on Patient Quality of Life
|
N/A | |
| Completed |
NCT02925494 -
An Extension Study to Evaluate the Efficacy and Safety of Elagolix in Premenopausal Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
| Recruiting |
NCT04959396 -
IUB SEAD RED (Revolutionary Endometrial Ablation Device Study
|
N/A | |
| Active, not recruiting |
NCT04778072 -
A Clinical Study on Adherence and Efficacy of Different Doses of Active Iron in Treatment Resistant Subjects
|
N/A | |
| Terminated |
NCT05026502 -
A Study to Assess Patient-Reported Quality of Life and Effectiveness on Control of Bleeding in Adult Participants With Heavy Menstrual Bleeding Due to Uterine Fibroids Taking Oral Oriahnn Capsules
|
||
| Recruiting |
NCT06064851 -
Delivering Transcutaneous Auricular Neurostimulation to Reduce Heavy Menstrual Bleeding in Von Willebrand Disease Patients
|
N/A | |
| Terminated |
NCT04132349 -
Ulipristal Acetate in Symptomatic Uterine Fibroid
|
Phase 4 | |
| Completed |
NCT00386308 -
Efficacy and Safety Study of XP12B in Women With Menorrhagia
|
Phase 3 | |
| Completed |
NCT03412890 -
LIBERTY EXTENSION: Efficacy and Safety Extension Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
| Active, not recruiting |
NCT04477837 -
Prospective Comparison of Incidence of Heavy Menstrual Bleeding in Women Treated With Direct Oral Anticoagulants
|
||
| Completed |
NCT05176496 -
A Study Called Champion-HMB to Learn More About Females With Heavy Menstrual Bleeding and Available Treatments to Enable Earlier Diagnosis and to Predict Courses of Treatment
|
||
| Completed |
NCT01431326 -
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
|
||
| Completed |
NCT00401193 -
Efficacy and Safety of XP12B in Women With Menorrhagia
|
Phase 3 | |
| Completed |
NCT03317795 -
Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids
|
Phase 4 | |
| Completed |
NCT02943655 -
Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause
|
Phase 3 | |
| Completed |
NCT03070951 -
Efficacy and Safety of OBE2109 in Subjects With Heavy Menstrual Bleeding Associated With Uterine Fibroids
|
Phase 3 | |
| Completed |
NCT05406960 -
Therapeutic Effect of Herbal Infusion on Menometrorrhagia
|
N/A | |
| Not yet recruiting |
NCT05079815 -
Heavy Menstrual Bleeding and Iron Deficiency Anemia
|
||
| Active, not recruiting |
NCT02449304 -
Evaluation of 4th Generation Bipolar Radiofrequency Endometrial Ablation Device
|
Phase 4 | |
| Terminated |
NCT02001324 -
HMB- Data Collection Methods
|
N/A |